Probiodrug AG To Publish First Half 2016 Results On 30 August 2016

HALLE (SAALE), Germany, 23 August 2016 – Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), will publish its results for the first six months of 2016 on Tuesday, August 30, 2016. The company will host a conference call, open to the public on August 30, 2016 at 15:00 Central European Summer Time (CEST).

The Results of the first six months of 2016 will be available for download on the company website (http://www.probiodrug.de/investors/reports-and-presentations/).